Publications
- Review of tumor infiltrating lymphocytes assessment in breast cancer in routine diagnostic practice2021 | First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Adjuvant T-DM1 versus trastuzumab in patients with residual invasive disease after neoadjuvant therapy for HER2-positive breast cancer: subgroup analyses from KATHERINE2021 | First Faculty of Medicine
- Adjuvantní léčba HER pozitivního karcinomu prsu2020 | First Faculty of Medicine
- Biologická léčba karcinomu prsu aktuálně2017 | First Faculty of Medicine
- Karcinom prsu - současnost a novinky v léčbě2016 | First Faculty of Medicine
- Uptake and Effectiveness of Risk-Reducing Surgeries in Unaffected Female BRCA1 and BRCA2 Carriers: A Single Institution Experience in the Czech Republic2023 | First Faculty of Medicine
- Preservation of fertility in young patients with breast cancer, including BRCA1, BRCA2 mutation carriers2023 | First Faculty of Medicine
- Trastuzumab deruxtecan in the treatment of patients with metastatic HER2‑low breast cancer2023 | First Faculty of Medicine
- Ultrasound appearance and targeted therapy of symptomatic neural lesions in the breast and chest wall after breast cancer surgery2023 | First Faculty of Medicine
- Bilateral Prophylactic Nipple-Sparing Mastectomy: Analysis of the Risk-Reducing Effect in BRCA1/2 Mutation Carriers2022 | First Faculty of Medicine
Loading network view...